Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

169 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT03958877

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • UC San Diego Health La Jolla, California, United States
  • UNC Hospitals Chapel Hill, North Carolina, United States
  • Meridian Clinical Research Norfolk, Virginia, United States
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
View all 65 locations
View Trial Details
Active, not recruiting

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

NCT03535298

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Colorado-Anschutz Medical Campus Aurora, Colorado, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada, United States
View all 30 locations
View Trial Details
Active, not recruiting

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

NCT06345157

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site L’Aquila, AQ, Italy
  • Novartis Investigative Site Bari, BA, Italy
  • Novartis Investigative Site Bergamo, BG, Italy
View all 31 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05201638

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neuro of Central Florida Altamonte Springs, Florida, United States
  • Healthcare Innovations Coral Springs, Florida, United States
  • Heratsi Hospital Complex 1 Yerevan, Armenia
  • Saint Gregory the Illuminator Medical Center Yerevan, Armenia
View all 76 locations
View Trial Details
Active, not recruiting

MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

NCT06095271

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University Hospital Basel Basel, Canton of Basel-City, Switzerland
  • Kantonsspital Aarau Aarau, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Hôpitaux Universitaires de Genève Geneva, Switzerland
View Trial Details

Related conditions